Novo Nordisk A/S (NVO)

Novo Nordisk Market Cap

Novo Nordisk has a market cap or net worth of $200.71 billion as of November 7, 2025. Its market cap has decreased by -61.55% in one year.

• Market Cap: 200.71B
• Enterprise Value: 211.35B
• 1-Year Change: -61.55%
• Ranking: #59
• Category: Mega-Cap
• Stock Price: $45.68

Market Cap Chart

Since December 1, 1998, Novo Nordisk's market cap has increased from $5.15B to $200.71B, an increase of 3,793.52%. That is a compound annual growth rate of 14.55%.

Market Cap History

Date	Market Cap	% Change
Nov 7, 2025	202.98B	-47.68%
Dec 31, 2024	387.95B	-17.76%
Dec 29, 2023	471.73B	54.12%
Dec 30, 2022	306.08B	19.24%
Dec 31, 2021	256.69B	55.86%
Dec 31, 2020	164.70B	16.14%
Dec 31, 2019	141.81B	23.12%
Dec 31, 2018	115.18B	-15.84%
Dec 29, 2017	136.86B	46.79%
Dec 30, 2016	93.24B	-38.18%
Dec 31, 2015	150.82B	29.59%
Dec 31, 2014	116.38B	12.48%
Dec 31, 2013	103.47B	9.30%
Dec 31, 2012	94.66B	36.88%
Dec 30, 2011	69.16B	-0.91%
Dec 31, 2010	69.79B	72.41%
Dec 31, 2009	40.48B	26.82%
Dec 31, 2008	31.92B	-22.43%
Dec 31, 2007	41.15B	52.03%
Dec 29, 2006	27.07B	44.82%
Dec 30, 2005	18.69B	1.87%
Dec 31, 2004	18.35B	29.73%
Dec 31, 2003	14.14B	41.73%
Dec 31, 2002	9.98B	25.01%
Dec 29, 2000	7.98B	36.89%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	827.67B
Johnson & Johnson	449.50B
AbbVie	387.34B
UnitedHealth Group	293.68B
AstraZeneca	263.38B
Novartis AG	243.48B
Abbott Laboratories	219.72B
Thermo Fisher Scientific	215.06B